Triumph Research Intelligence
Triumph Research Intelligence is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
APOLLO: A Randomized, Double-Blind, Placebo-Controlled Study of Bitopertin to Evaluate the Efficacy, Safety, and Tolerability in Participants with Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
Sponsor Disc Medicine Inc.
- Start (EU)
- Latest update
- Estimated end
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Safety, Tolerability and Efficacy of AGA2118 in Postmenopausal Women with Low Bone Mineral Density
Sponsor Angitia Inc. Ltd.
- Start (EU)
- Latest update
- Estimated end
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety and Efficacy of AGA2115 in Adults with Type I, III, or IV Osteogenesis Imperfecta (OI)
Sponsor Angitia Inc. Ltd.
- Start (EU)
- Not reported
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Triumph Research Intelligence?
The 2026-10-09 snapshot links Triumph Research Intelligence to 3 distinct CTIS trials. Recorded services include Risk management and central monitoring activities, Risk Based Quality Management. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Triumph Research Intelligence?
The most frequently recorded therapeutic areas are Metabolic Disorders, Dermatology, Genetic and Congenital Disorders, Musculoskeletal. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Triumph Research Intelligence conducted?
The linked trials record locations in 13 countries, including Denmark, France, Netherlands, Belgium, Bulgaria. These are trial locations, not confirmed office locations or countries where Triumph Research Intelligence delivered services.
What can this page tell me about Triumph Research Intelligence's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Triumph Research Intelligence. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Triumph Research Intelligence Limited